Abstract | OBJECTIVES: One proposed mechanism of lithium action in the treatment of bipolar disorder is that Li+ competes with Mg2+ for Mg2+ binding sites within the cell. In this study, we investigated this competition at therapeutic intracellular Li+ levels in human neuroblastoma SH-SY5Y cells. METHODS: We used fluorescence spectroscopy and a Mg2+ indicator, furaptra, to investigate this competition in human neuroblastoma SH-SY5Y cells. Atomic absorption spectrophotometry was used for determination of the intracellular Li+ levels. RESULTS: The neuroblastoma cells, incubated in 15 mM or 30 mM Li+-containing buffer, showed a significant increase in free intracellular Mg2+ levels [using a positive linear within-groups contrast t-test, the 15 mM condition produced t(2) = 5.0, one-tailed p < 0.02, and the 30 mM Li+-incubation conditions gave t(2) = 9.2, one-tailed p < 0.006] but did not significantly increase over time in the Li+-free condition [t(2) = 0.1, one-tailed p > 0.96]. At the earlier times during the incubation (1 or 10 min for the 15 mM or 30 mM Li+-containing buffers), the intracellular Li+ concentrations were 0.6-2.5 mM, values which are comparable to those reached in the brain of Li+-treated patients. CONCLUSION: We demonstrated that competition between Li+ and Mg2+ can occur at therapeutic intracellular Li+ levels.
|
Authors | B Layden, C Diven, N Minadeo, F B Bryant, D Mota de Freitas |
Journal | Bipolar disorders
(Bipolar Disord)
Vol. 2
Issue 3 Pt 1
Pg. 200-4
(Sep 2000)
ISSN: 1398-5647 [Print] Denmark |
PMID | 11256688
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Ion Channels
- Lithium
- Magnesium
|
Topics |
- Bipolar Disorder
(drug therapy, metabolism)
- Humans
- Intracellular Fluid
(metabolism)
- Ion Channels
(drug effects, metabolism)
- Ion Transport
(drug effects)
- Lithium
(metabolism, pharmacology)
- Magnesium
(metabolism)
- Neuroblastoma
(metabolism)
- Spectrophotometry, Atomic
- Tumor Cells, Cultured
|